Fleury ME - Search Results

1

Feasibility of Cancer Clinical Trial Enrollment Goals Based on Cancer Incidence.

Tran G, Harker M, Chiswell K, Unger JM, Fleury ME, Hirsch B, Miller K, d'Almada P, Tibbs S, Zafar SY. Tran G, et al. Among authors: fleury me. JCO Clin Cancer Inform. 2020 Jan;4:35-49. doi: 10.1200/CCI.19.00088. JCO Clin Cancer Inform. 2020. PMID: 31977253

2

Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.

Unger JM, Hershman DL, Fleury ME, Vaidya R. Unger JM, et al. Among authors: fleury me. JAMA Oncol. 2019 Mar 1;5(3):326-333. doi: 10.1001/jamaoncol.2018.5953. JAMA Oncol. 2019. PMID: 30629092 Free PMC article.

3

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.

Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME. Unger JM, et al. Among authors: fleury me. J Natl Cancer Inst. 2019 Mar 1;111(3):245-255. doi: 10.1093/jnci/djy221. J Natl Cancer Inst. 2019. PMID: 30856272 Free PMC article.

4

Reimbursing Patients for Participation in Cancer Clinical Trials.

Unger JM, Fleury ME. Unger JM, et al. Among authors: fleury me. JAMA Oncol. 2019 Jul 1;5(7):932-934. doi: 10.1001/jamaoncol.2019.0141. JAMA Oncol. 2019. PMID: 31169875 No abstract available.

5

"When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.

Unger JM, Hershman DL, Till C, Minasian LM, Osarogiagbon RU, Fleury ME, Vaidya R. Unger JM, et al. Among authors: fleury me. J Natl Cancer Inst. 2021 Mar 1;113(3):244-257. doi: 10.1093/jnci/djaa155. J Natl Cancer Inst. 2021. PMID: 33022716 Free PMC article.

6

Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical Trials.

Fleury ME, Farner AM, Unger JM. Fleury ME, et al. JAMA Oncol. 2021 Jan 1;7(1):131-132. doi: 10.1001/jamaoncol.2020.5748. JAMA Oncol. 2021. PMID: 33180102 Free PMC article.

7

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group.

Magnuson A, Bruinooge SS, Singh H, Wilner KD, Jalal S, Lichtman SM, Kluetz PG, Lyman GH, Klepin HD, Fleury ME, Hirsch B, Melemed A, Arnaldez FI, Basu Roy U, Schenkel C, Sherwood S, Garrett-Mayer E. Magnuson A, et al. Among authors: fleury me. Clin Cancer Res. 2021 May 1;27(9):2424-2429. doi: 10.1158/1078-0432.CCR-20-3868. Epub 2021 Feb 9. Clin Cancer Res. 2021. PMID: 33563633 Free PMC article. Review.

8

Patient Willingness to Enroll in Cancer Clinical Trials When Sites Return to Prepandemic Status-Reply.

Fleury ME, Unger JM. Fleury ME, et al. JAMA Oncol. 2021 Jun 1;7(6):940. doi: 10.1001/jamaoncol.2021.0387. JAMA Oncol. 2021. PMID: 33792633 No abstract available.

9

Strategies to Advance Equity in Cancer Clinical Trials.

Guerra CE, Fleury ME, Byatt LP, Lian T, Pierce L. Guerra CE, et al. Among authors: fleury me. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-11. doi: 10.1200/EDBK_350565. Am Soc Clin Oncol Educ Book. 2022. PMID: 35687825 Free article.

10

Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical Trials.

Adams DV, Long S, Fleury ME. Adams DV, et al. Among authors: fleury me. JAMA Netw Open. 2022 Jul 1;5(7):e2220053. doi: 10.1001/jamanetworkopen.2022.20053. JAMA Netw Open. 2022. PMID: 35788672 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters